WE SEE THE FUTURE FIRST

WE SEE THE FUTURE FIRST

Minerva Biotechnologies is focused on cancer and stem cell therapeutics. We are developing cancer immunotherapies targeting 80% of solid tumors and to prevent cancer metastasis

more info
patternframe

Welcome to Minerva Biotechnologies

Exploring the Space between Cancers and Stem Cells

Cancer Therapeutics

Cancer Therapeutics

Minerva's CAR T therapeutics will attack solid tumors that are MUC1* positive. This represents approximately 80% of all cancers.

learn more
Regenerative Medicine

Regenerative Medicine

Minerva’s stem cell discoveries will enable pharmaceutical companies to utilize regenerative medicine in a variety of diseases

learn more
Stem Cells

Stem Cells

Using NME7AB, iPSC generation is 50x more efficient, cell growth is more scalable, and resulting cells have improved functionality

learn more

We See The Future First.

Minerva Presenting at 10yrs of iPSCs Symposium 

featured news

Minerva Presenting at 10yrs of iPSCs Symposium 

Dr. Cynthia Bamdad, CEO and Founder of Minerva Biotechnologies, will be presenting a poster at the 10yrs of iPSCs Symposium in Berkeley, CA...

Posted on September 26, 2016

view more DETAILS

Latest News

November 7, 2016

Job Opening - Research Scientist, Immunotherapy​

Research Scientist,  Immunotherapy​ It started with a simple hypothesis

September 26, 2016

Minerva Presenting at 10yrs of iPSCs Symposium 

Dr. Cynthia Bamdad, CEO and Founder of Minerva Biotechnologies, will be presenting a

July 10, 2016

Job Opening - Research Associate

Minerva Biotechnologies is a rapidly growing company soon to enter into clinical trials

View All News

We See The Future First.

Sign Up For Our Mailing List.